Search

Your search keyword '"Bas J M Peters"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Bas J M Peters" Remove constraint Author: "Bas J M Peters"
24 results on '"Bas J M Peters"'

Search Results

1. Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands

2. Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients

3. Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer

4. The potential for deprescribing in a palliative oncology patient population: a cross-sectional study

5. Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients

6. Recurrent Episodes of Nivolumab-Induced Pneumonitis after Nivolumab Discontinuation and the Time Course of Carcinoembryonic Antigen Levels: A Case of a 58-Year-Old Woman with Non-Small Cell Lung Cancer

7. Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC)

8. Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer (ED SCLC)

9. The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population

10. Treatment of oncogene-driven non-small cell lung cancer

11. Utilization of Molecular Testing and Survival Outcomes of Treatment with First- or Second-line Tyrosine Kinase Inhibitors in Advanced Non-small Cell Lung Cancer in a Dutch Population

12. The SLCO1B1 c.521T > C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study

13. Validation of an automated method for compounding monoclonal antibody patient doses

14. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

15. Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI

16. Methodological and statistical issues in pharmacogenomics

18. CYP2C19 and ABCB1 genes and individualized treatment with clopidogrel

19. Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction

20. Genetic determinants of response to statins

21. The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study

22. Pharmacogenomic importance of pravastatin

23. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant

24. Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height

Catalog

Books, media, physical & digital resources